These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6362751)

  • 1. Immunoaffinity purification of bovine factor VII.
    Bach R; Oberdick J; Nemerson Y
    Blood; 1984 Feb; 63(2):393-8. PubMed ID: 6362751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and properties of human coagulation factor VII.
    Broze GJ; Majerus PW
    J Biol Chem; 1980 Feb; 255(4):1242-7. PubMed ID: 7354023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII.
    Nakagaki T; Foster DC; Berkner KL; Kisiel W
    Biochemistry; 1991 Nov; 30(45):10819-24. PubMed ID: 1932002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human factor VII by factors IXa and Xa on human bladder carcinoma cells.
    Wildgoose P; Kisiel W
    Blood; 1989 May; 73(7):1888-95. PubMed ID: 2785418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of Factor VII from bovine plasma. Reaction with tissue factor and activation of Factor X.
    Jesty J; Nemerson Y
    J Biol Chem; 1974 Jan; 249(2):509-15. PubMed ID: 4809529
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and characterization of human factor VII. Activation of factor VII by factor Xa.
    Bajaj SP; Rapaport SI; Brown SF
    J Biol Chem; 1981 Jan; 256(1):253-9. PubMed ID: 6778860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
    Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
    J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of bovine factor VII.
    Kisiel W; Davie EW
    Biochemistry; 1975 Nov; 14(22):4928-34. PubMed ID: 1182130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.
    Novotny WF; Girard TJ; Miletich JP; Broze GJ
    J Biol Chem; 1989 Nov; 264(31):18832-7. PubMed ID: 2553722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). Implications for the initiation of the extrinsic pathway of blood coagulation.
    Sakai T; Lund-Hansen T; Paborsky L; Pedersen AH; Kisiel W
    J Biol Chem; 1989 Jun; 264(17):9980-8. PubMed ID: 2785997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoaffinity purification and characterization of lipoprotein-associated coagulation inhibitors from Hep G2 hepatoma, Chang liver, and SK hepatoma cells. A comparative study.
    Wun TC; Huang MD; Kretzmer KK; Palmier MO; Day KC; Bulock JW; Fok KF; Broze GJ
    J Biol Chem; 1990 Sep; 265(27):16096-101. PubMed ID: 2168880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity.
    Neuenschwander PF; Morrissey JH
    J Biol Chem; 1992 Jul; 267(20):14477-82. PubMed ID: 1629232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of human factor VII utilizing O-(diethylaminoethyl)-Sephadex and Sulfopropyl-Sephadex chromatography.
    Rao LV; Bajaj SP
    Anal Biochem; 1984 Feb; 136(2):357-61. PubMed ID: 6609650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, purification, and characterization of an Arg152----Glu site-directed mutant of recombinant human blood clotting factor VII.
    Wildgoose P; Berkner KL; Kisiel W
    Biochemistry; 1990 Apr; 29(13):3413-20. PubMed ID: 1970743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of a proteolytic system by a membrane lipoprotein: mechanism of action of tissue factor.
    Nemerson Y; Esnouf MP
    Proc Natl Acad Sci U S A; 1973 Feb; 70(2):310-4. PubMed ID: 4510277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.
    Broze GJ; Warren LA; Novotny WF; Higuchi DA; Girard JJ; Miletich JP
    Blood; 1988 Feb; 71(2):335-43. PubMed ID: 3422166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
    Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that an Arg79-->Gln substitution in human factor VII is not associated with a reduction in coagulant activity.
    Kazama Y; Foster DC; Kisiel W
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):697-702. PubMed ID: 1489892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII.
    Radcliffe R; Nemerson Y
    J Biol Chem; 1975 Jan; 250(2):388-95. PubMed ID: 234427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of blood coagulation factors II, VII, IX and X from bovine citrated plasma.
    Reekers P; Hemker HC
    Haemostasis; 1972; 1(1):2-22. PubMed ID: 4668761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.